Cargando…

Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer

The expansion of cancer-induced myeloid cells is thought to be one of the main obstacles to successful immunotherapy. Nevertheless, in murine tumors undergoing immune-mediated destruction by adoptively transferred T cells, we have recently shown that such cells maintain their immunosuppressive prope...

Descripción completa

Detalles Bibliográficos
Autor principal: Arina, Ainhoa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063155/
https://www.ncbi.nlm.nih.gov/pubmed/25050213
http://dx.doi.org/10.4161/onci.28464
_version_ 1782321757189832704
author Arina, Ainhoa
author_facet Arina, Ainhoa
author_sort Arina, Ainhoa
collection PubMed
description The expansion of cancer-induced myeloid cells is thought to be one of the main obstacles to successful immunotherapy. Nevertheless, in murine tumors undergoing immune-mediated destruction by adoptively transferred T cells, we have recently shown that such cells maintain their immunosuppressive properties. Therefore, adoptive T-cell therapy can, under certain conditions, overcome myeloid cell immunosuppression.
format Online
Article
Text
id pubmed-4063155
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-40631552015-04-15 Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer Arina, Ainhoa Oncoimmunology Author's View The expansion of cancer-induced myeloid cells is thought to be one of the main obstacles to successful immunotherapy. Nevertheless, in murine tumors undergoing immune-mediated destruction by adoptively transferred T cells, we have recently shown that such cells maintain their immunosuppressive properties. Therefore, adoptive T-cell therapy can, under certain conditions, overcome myeloid cell immunosuppression. Landes Bioscience 2014-04-15 /pmc/articles/PMC4063155/ /pubmed/25050213 http://dx.doi.org/10.4161/onci.28464 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Arina, Ainhoa
Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title_full Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title_fullStr Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title_full_unstemmed Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title_short Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
title_sort rethinking the role of myeloid-derived suppressor cells in adoptive t-cell therapy for cancer
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063155/
https://www.ncbi.nlm.nih.gov/pubmed/25050213
http://dx.doi.org/10.4161/onci.28464
work_keys_str_mv AT arinaainhoa rethinkingtheroleofmyeloidderivedsuppressorcellsinadoptivetcelltherapyforcancer